The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Prevalence and Pathologic Features of Sickle Cell Nephropathy and Response to Inhibition of Angiotensin-Converting Enzyme
Open accessAbstract
BACKGROUND: Nephropathy may develop in patients with sickle cell disease. We determined the prevalence of proteinuria and renal insufficiency in a group of patients with sickle cell disease and investigated the renal pathologic changes and the effects of an angiotensin-converting-enzyme inhibitor (enalapril) on protein excretion in patients found to have nephropathy. METHODS: We prospectively screened 381 patients with sickle cell disease for the presence of proteinuria and renal insufficiency. Renal biopsy and measurements of glomerular filtration rate, effective renal plasma flow, and urinary protein excretion were performed in 10 patients with mild nephropathy before and after the administration of enalapril, and again two to three weeks after its discontinuation. RESULTS: Of the 381 patients with sickle cell disease, 26 (7 percent) had serum creatinine concentrations above the normal range and 101 (26 percent) had proteinuria of at least 1+. The renal lesions in the 10 patients who had biopsies consisted of glomerular enlargement and perihilar focal segmental glomerulosclerosis. The mean (+/- SD) glomerular area in these patients was 28.7 +/- 4.1 x 10(3) micron 2, as compared with 15.8 +/- 4.3 x 10(3) micron 2 in 10 control patients without renal disease who had died of trauma (P less than 0.0001). During the administration of enalapril, the mean 24-hour urinary protein excretion decreased 57 percent (range, 23 to 79 percent) below the base-line value (P less than 0.001), and it increased to 25 percent below the base-line value after enalapril was discontinued. The glomerular filtration rate and effective renal plasma flow did not change significantly. CONCLUSIONS: Approximately 25 percent of patients with sickle cell disease have proteinuria. Treatment with enalapril reduces the degree of proteinuria in these patients, suggesting that glomerular capillary hypertension may be a pathogenic factor in sickle cell nephropathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prediction of Creatinine Clearance from Serum Creatinine
Cockcroft, D. W., & Gault, H. (1976) · Nephron · doi:10.1159/000180580 · Cited by 15,309
Smith, H. W., Finkelstein, N., Aliminosa, L., Crawford, B., & Graber, M. (1945) · Journal of Clinical Investigation · doi:10.1172/jci101618 · Cited by 1,585
Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass.
Anderson, S., Meyer, T. W., Rennke, H. G., & Brenner, B. M. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112013 · Cited by 932
Olson, J. L., Hostetter, T. H., Rennke, H. G., Brenner, B. M., & Venkatachalam, M. A. (1982) · Kidney International · doi:10.1038/ki.1982.143 · Cited by 353
SIMPLIFICATION OF THE ANTHRONE METHOD FOR THE DETERMINATION OF INULIN IN CLEARANCE STUDIES.
Davidson, W. D., & Sackner, M. A. (1963) · PubMed · Cited by 298
Causes of death in sickle-cell disease in Jamaica.
Thomas, A. N., Pattison, C., & Serjeant, G. R. (1982) · BMJ · doi:10.1136/bmj.285.6342.633 · Cited by 266
Angiotensin Converting Enzyme Inhibitors and Progressive Renal Insufficiency
Keane, W. F., Anderson, S., Aurell, M., de Zeeuw, D., Narins, R. G., & Povar, G. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-111-6-503 · Cited by 155
García, D. L., Anderson, S., Rennke, H. G., & Brenner, B. M. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.16.6142 · Cited by 151
Angiotensin converting enzyme inhibition improves glomerular size-selectivity in IgA nephropathy
Remuzzi, A., Perticucci, E., Ruggenenti, P. L., et al. (1991) · Kidney International · doi:10.1038/ki.1991.160 · Cited by 147
Sickle cell nephropathy: New insights into its pathophysiology
de Jong, P. E., & van Eps, L. W. S. (1985) · Kidney International · doi:10.1038/ki.1985.70 · Cited by 117
Cited by
Rees, D. C., Williams, T. N., & Gladwin, M. T. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61029-x · Cited by 2,504
Kato, G. J., Piel, F. B., Reid, C. D., Gaston, M. H., Ohene-Frempong, K., Krishnamurti, L., Smith, W. R., Panepinto, J. A., Weatherall, D. J., Costa, F. F., et al. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.10 · Cited by 1,501
Interactions of Transforming Growth Factor-β and Angiotensin II in Renal Fibrosis
Border, W. A., & Noble, N. A. (1998) · Hypertension · doi:10.1161/01.hyp.31.1.181 · Cited by 447
A Short-Term Trial of Butyrate to Stimulate Fetal-Globin-Gene Expression in the β-Globin Disorders
Perrine, S. P., Ginder, G. D., Faller, D. V., Dover, G. H., Ikuta, T., Witkowska, H. E., Cai, S.-P., Vichinsky, E. P., & Olivieri, N. F. (1993) · New England Journal of Medicine · doi:10.1056/nejm199301143280202 · Cited by 437
Klings, E. S., Machado, R. F., Barst, R. J., Morris, C. R., Mubarak, K. K., Gordeuk, V. R., Kato, G. J., Ataga, K. I., Gibbs, J. S., Castro, O., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201401-0065st · Cited by 263
Metadata
- Authors
- Falk, R. J., Scheinman, J., Phillips, G., Orringer, E., Johnson, A., & Jennette, J. C.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1992-04-02
- Volume
- 326
- Issue
- 14
- Pages
- 910-915
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2332473024
- Cited by
- 300
- References
- 23
- FWCI
- 4.70
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prevalence and Pathologic Features of Sickle Cell Nephropathy and Response to Inhibition of Angiotensin-Converting Enzyme. https://app.cochat.ai/papers/10.1056/nejm199204023261402
- The paper
- Falk, R. J., Scheinman, J., Phillips, G., Orringer, E., Johnson, A., & Jennette, J. C. (1992). Prevalence and Pathologic Features of Sickle Cell Nephropathy and Response to Inhibition of Angiotensin-Converting Enzyme. New England Journal of Medicine. https://doi.org/10.1056/nejm199204023261402
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.